gallery/picture1

Technology

Our technology involves the engineering and fabrication of erythrocyte-derived vesicles with tunable diameters and containing appropriate formulations of probes for image-guided therapeutics of solid cancers and vascular diseases on an individual patient basis.

 

            • RBC-based nano and micro particles

            • Ease of custom targeting various cancer biomarkers

            • Platform for combined chemo- and photo-therapeutics

 

In relation to cancer imaging and therapy, Radoptics technologies can provide a capability  for image-guided surgical removal of small tumor nodules that are not otherwise visually detectable during surgery, or pre-operatively by current imaging methods, and mediate destruction of tumor cells through a combination of chemotherapy and pulsed near infrared thermal therapy.

Patents

  • Mechanically-tuned erythrocyte-derived optical particles for theranostics, pending.
  • Membrane-cholesterol enriched fabricated from red blood cells for biomedical applications, pending.
  • Camouflaged phosphatidylserine particles fabricated from red blood cells for biomedical applications, pending.
gallery/picture2